ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658093 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658093; 2) Community: the network communities that were significantly associated with the response to NSC 658093; 3) Molecule: the relationships between components within communities and NSC 658093; 4) MDR: the compounds that were significantly associated with the NSC 658093.

NSC Compound Enrichment Correlation
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0406225271888776 0.5092901
NSC 761816 (Z)-3-((1-(3,4,5-trimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0406225271888776 0.26946383
NSC 80141 Null 0.0406225271888776 -0.12270708
NSC 688816 Null 0.0406225271888781 0.020630549
NSC 728323 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0406225271888781 0.12242313
NSC 109555 DDUG 0.0407060322613561 0.085955824
NSC 268665 Null 0.0407060322613561 0.19519975
NSC 34475 Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8CI) 0.0407060322613561 0.20120736
NSC 49520 o-Tolualdehyde, 4-(bis(2-chloroethyl)amino)- 0.0407060322613561 0.531498
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0407060322613561 0.47417933
Total:63  Current:56    [First] [Prev] [Next] [Last]